David Bearss is featured in Biosphere Magazine

David Bearss’ passion for drug discovery has guided his noteworthy career as a dynamic leader who integrates scientific and business interests to deliver new medicines to patients. That passion is still evident today as he gives back to the industry he loves, making a difference with bold initiatives to improve health and change the face of Utah’s life sciences ecosystem.

Targeting a Regulator of Inflammation to Treat Alzheimer’s Disease

The Bio Report David Bearss Ph.D., president and CEO of Halia Therapeutics, Inc., discusses with Daniel Levine the NLRP3 inflammasome, the role it plays in Alzheimer’s disease and other neurologic conditions, and the case for the company's therapeutic approach....

Empowered Patient Podcast episode featuring David J. Bearss

Empowered Patient Podcast David Bearss the Co-Founder, CEO and President of Halia Therapeutics, points out that despite traditional thinking, chronic inflammation is not just an unresolved acute inflammatory response. It has been discovered that a different pathway...

Contact Us

Corporate Headquarters

3900 N. Traverse Mountain Blvd., Suite 100
Lehi, Utah 84043
United States

info@haliatx.com |  +1 (385) 355-4315